News
November 7, 2008
Positive CNS/PNS effect data in Alpha-mannosidosis mouse model presented in Prague
May 6, 2008
Zymenex hosts European Alpha-mannosidosis Disease Group meeting
Innovation for Quality of Life

We are engaged in the research and development of innovative therapeutics for life threatening diseases

Zymenex A/S Roskildevej 12 C
3400 Hillerød, DK		 Tel  +45 48250054
Fax  +45 48251054		 Affiliate Sweden Dalénum 13
181 70 Lidingö, S		 Tel  +46 8 7670203
Fax  +46 8 7670233
© 2004 Zymenex A/S